These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 6106834)
1. The dexamethasone test and depression. Lancet; 1980 Oct; 2(8197):730. PubMed ID: 6106834 [No Abstract] [Full Text] [Related]
2. [Use of the dexamethasone test in the differential diagnosis of depressive states]. Nuller IuL; Ostroumova MN; Gordon OI Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705 [TBL] [Abstract][Full Text] [Related]
3. [The dexamethasone suppression test in affective disorders. A review]. Charles G; Wilmotte J; Mendlewicz J Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064 [TBL] [Abstract][Full Text] [Related]
4. [Re-analysis of the diagnostic significance of the dexamethasone suppression test in depression]. Shen QJ Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):279-83. PubMed ID: 3833512 [No Abstract] [Full Text] [Related]
5. [Dexamethasone test in the diagnosis and treatment of affective psychoses]. Evsegneev RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):98-101. PubMed ID: 2750393 [TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test as an adjunct in diagnosing depression. Lawson WB; Herrera JM; Costa J J Assoc Acad Minor Phys; 1992; 3(1):17-9. PubMed ID: 1576455 [TBL] [Abstract][Full Text] [Related]
9. The overnight dexamethasone suppression test: clinical and theoretical review. Gwirtsman H; Gerner RH; Sternbach H J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505 [TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine evaluation of depression in borderline patients. Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239 [No Abstract] [Full Text] [Related]
11. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities. Kraus RP; Remick RA J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719 [TBL] [Abstract][Full Text] [Related]
12. Anxiety/depression: current management and future directions. Biologic markers and treatment response. Carroll BJ J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):30-40. PubMed ID: 6348035 [TBL] [Abstract][Full Text] [Related]
13. The dexamethasone suppression test in psychiatry. Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036 [TBL] [Abstract][Full Text] [Related]
15. The dexamethasone suppression test and unipolar/bipolar distinctions. Zisook S; Janowsky DS; Overall JE; Risch SC J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705 [TBL] [Abstract][Full Text] [Related]
16. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518 [TBL] [Abstract][Full Text] [Related]
17. Bipolar illness, catatonia, and the dexamethasone suppression test in adolescence: case report. Hall DC; Ries RK J Clin Psychiatry; 1983 Jun; 44(6):222-4. PubMed ID: 6406474 [TBL] [Abstract][Full Text] [Related]